Aegerion Pharmaceuticals 2013 EU Payment Disclosures

In This Section

United Kingdom – Healthcare Professionals (in accordance with the Association of the British Pharmaceutical Industry Code of Practice for the Pharmaceutical Industry)

  • A total of 17 UK health care professionals received consultancy payments of £25,310. These payments related to services provided to Aegerion in relation to chairing and participation in advisory boards and preparation of patient dietary support materials. Payments represented fair market value for the services provided. In addition, the following expenses were paid to these individuals: £1,810 on UK travel, £972 on foreign travel and £107 on accommodation.
  • No UK healthcare professionals were sponsored to attend meetings in 2013.

 

Patient Organizations

In accordance with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice on relationships between the pharmaceutical industry and patient organizations, we are providing the following listing of patient organizations in the European Union that the Aegerion Pharmaceuticals group supported in 2013:
 

Patient Organization Project/Support Amount (Currency)
Heart UK Sponsorship and exhibition stand at the Heart UK annual meeting, which took place in July 2013 £6970
(British Pounds)
Patientforeningen FHSverige (Sweden) Financial support for FH educational and awareness activities SEK25,000
(Swedish Kroner)
FHchol Austria Sponsorship of a journalist workshop "Journalistenworkshop Familiäre Hypercholesterinämie", which took place in Vienna in March 2013 €4,000
(Euros)
Cholesterin & Co e.V. (CholCo) (Germany) Sponsorship of CholCo annual meeting, which took place in Frankfurt in June 2013 €3,500
(Euros)
De Hart & Vaatgroep (Heart & Vascular Group) (Netherlands) Financial support for FH/HoFH educational and awareness activities €2,500
(Euros)